VHT — Vanguard Health Care Index Fund ETF Shares
Healthcare Ranked #65 of 458 tracked ETFs · Issued by Vanguard
VHT Price Performance — Growth of $10,000
Value of a $10,000 investment in VHT over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.
VHT Drawdown
The "underwater" chart: VHT's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.
What If You'd Invested in VHT?
See what a lump sum in VHT would have grown to, with the option to add a regular monthly contribution on top. Figures use total returns — dividends are assumed reinvested.
Past performance doesn't predict future results. Assumes contributions on the first trading day of each month, no trading costs or taxes, and reinvested distributions. History is limited to the range published in the site's daily return data.
Overview
The Vanguard Health Care Index Fund ETF Shares is a healthcare-focused fund issued by Vanguard with $21.8 billion in assets. It holds a B grade and ranks 1 of 11 within its category, placing it at #65 overall among 458 tracked ETFs. The fund’s 0.09% expense ratio is significantly lower than the category median of 0.36%, while its 1.46% dividend yield exceeds the median of 1.05%. Top holdings constitute 51.9% of assets, with Eli Lilly & Co representing the largest single position at 14.0%.
The fund’s price of $315.31 sits at 77.2% of its 52-week range, reflecting a recent downgrade from B+ to B on 2026-10-02. Short-term returns show a slight dip over one week at -0.24%, contrasting with a stronger 19.34% gain over the past year. This one-year performance matches the category median exactly, while longer-term data shows a 40.67% return over three years. The available price history covers only 3.0 years, limiting the depth of long-term trend analysis.
With a beta of 0.57, the fund exhibits lower sensitivity to market movements compared to the broader index. Its annualized volatility of 15.18% is labeled as Moderate, accompanied by a Sharpe ratio of 0.94 that indicates reasonable risk-adjusted returns. The maximum drawdown of -16.91% highlights the peak-to-trough decline experienced during the measurement period. Liquidity is supported by an average daily volume of 209,496 shares, facilitating standard trading activity.
AI-generated summary based on the data on this page.
VHT Top Holdings
| # | Holding | % of Net Assets | Value |
|---|---|---|---|
| 1 | Eli Lilly & Co | 14.04% | $2.67B |
| 2 | Johnson & Johnson | 8.47% | $1.61B |
| 3 | AbbVie Inc | 6.09% | $1.16B |
| 4 | UnitedHealth Group Inc | 5.45% | $1.03B |
| 5 | Merck & Co Inc | 4.66% | $885M |
| 6 | Thermo Fisher Scientific Inc | 2.93% | $556M |
| 7 | Amgen Inc | 2.87% | $545M |
| 8 | Gilead Sciences Inc | 2.64% | $501M |
| 9 | Intuitive Surgical Inc | 2.38% | $452M |
| 10 | Pfizer Inc | 2.35% | $447M |
Holdings as of 2026-05-31 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 51.9% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how VHT's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.
Which Funds Overlap With VHT
Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with VHT's top 10 — XLV overlaps most, holding 9 of the same companies as VHT's top 10 (49.5% of VHT's assets).
| ETF | Name | Shared Companies | VHT Weight | Examples |
|---|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | 9 | 49.5% | Eli Lilly & Co, Johnson & Johnson, AbbVie Inc… |
| FHLC | Fidelity MSCI Health Care Index ETF | 9 | 49.5% | Eli Lilly & Co, Johnson & Johnson, AbbVie Inc… |
| IYH | iShares U.S. Healthcare ETF | 8 | 35.5% | Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc… |
| PPH | VanEck Pharmaceutical ETF | 5 | 35.6% | Eli Lilly & Co, Merck & Co Inc, Johnson & Johnson… |
| VTV | Vanguard Morningstar Value ETF | 3 | 20.0% | Johnson & Johnson, AbbVie Inc, UnitedHealth Group Inc |
Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.
Market Backdrop
10-Year Treasury Yield: 5.27% (as of 2026-10-06) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.
CBOE Volatility Index (VIX): 15.01 (as of 2026-10-06) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.
Federal Funds Rate: 3.75% (as of 2026-09-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.
What VHT's Fees Cost You
VHT charges an expense ratio of 0.09% a year, deducted automatically from the fund's value. Small percentages compound into real money — adjust the figures below to see the impact on your own numbers.
Assumes a constant gross return and no additional contributions — a simplification, but it isolates exactly what the expense ratio costs. Try the full fee calculator to model contributions and compare any two funds.
VHT Dividend Income Estimator
VHT currently yields 1.46%. Enter an amount to see the income that implies, or set a monthly income target to see the investment it would take.
Based on the fund's current trailing yield, which varies with price and distributions — treat it as an estimate, not a guarantee. Yields are not adjusted for tax.
VHT Liquidity, Domicile & Tax Treatment
Liquidity: Average daily volume is 209K/day. Higher volume and a larger fund generally mean lower round-trip trading costs. AUM of $21.8B provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.
Domicile & tax treatment: VHT is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.
VHT Performance History
| Period | Return |
|---|---|
| 1-Day | +0.78% |
| 1-Week | -0.24% |
| 1-Month | +0.53% |
| 3-Month | +3.17% |
| 6-Month | +14.08% |
| YTD | +10.32% |
| 1-Year | +19.34% |
| 3-Year | +40.67% |
How VHT Compares to Other Healthcare ETFs
| Rank | Grade | Ticker | Name | 1-Year | Exp. Ratio | AUM |
|---|---|---|---|---|---|---|
| #65 | B |
VHT | Vanguard Health Care Index Fund ETF Shares | +19.34% | 0.09% | $21.8B |
| #69 | B |
XLV | State Street Health Care Select Sector SPDR ETF | +19.09% | 0.08% | $43.4B |
| #97 | B |
XBI | State Street SPDR S&P Biotech ETF | +45.58% | 0.35% | $10.4B |
| #101 | B |
FHLC | Fidelity MSCI Health Care Index ETF | +19.46% | 0.084% | $3.54B |
| #123 | B |
IBB | iShares Biotechnology ETF | +35.36% | 0.44% | $11.2B |
| #169 | C |
IYH | iShares U.S. Healthcare ETF | +18.57% | 0.37% | $3.96B |
| #173 | B |
XPH | State Street SPDR S&P Pharmaceuticals ETF | +29.90% | 0.35% | $524M |
| #193 | C |
ARKG | ARK Genomic Revolution ETF | +65.04% | 0.75% | $2.22B |
| #195 | C |
PPH | VanEck Pharmaceutical ETF | +19.21% | 0.36% | $1.02B |
| #382 | D |
IHF | iShares U.S. Healthcare Providers ETF | +12.12% | 0.37% | $1.36B |
| #434 | F |
IHI | iShares U.S. Medical Devices ETF | -15.11% | 0.37% | $3.45B |